> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Cannabis and Cannabis-Derived Compounds
- URL: https://www.fdaweb.com/draft-guide-on-cannabis-and-cannabis-derived-compounds/
- Published: 2020-07-22T12:00:00.000Z
- Updated: 2026-09-14T16:22:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147255

*Federal Register* notice: FDA has made available a draft guidance entitled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research.” The document outlines FDA’s current thinking on general quality considerations for developing drugs that contain cannabis and cannabis-derived compounds, and the calculation of percent delta-9 tetrahydrocannabinol (THC) in botanical raw materials, extracts, and finished products. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-07-22/pdf/2020-15907.pdf?ref=fdaweb.com).